Privia Health Group, Inc. PRVA 深 沪
等待开盘 06-30 09:30:00 美东时间
25.55
-0.020
-0.08%
华盛通- 最 高25.71
- 今 开25.37
- 成交量 136.56万股
- 最 低 25.14
- 昨 收 25.57
- 总市值 32.20亿
- 52周最高 26.51
- 市盈率 静 143.70
- 换手率 1.08%
- 52周最低 18.77
- 委 比 -40.12%
- 总股本 1.26亿
- 历史最高 50.77
- 量 比 0.85
- 振 幅 2.23%
- 历史最低 15.92
- 每 手 1
- 风险率 1.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Privia Health Enters New Jersey
Privia Health Group announced its entry into New Jersey through a partnership with Neurology Group of Bergen County (NGBC), a leading neurology practice. NGBC will serve as the anchor practice for Privia Medical Group—New Jersey, integrating into the Privia Platform by year-end 2026. The collaboration aims to enhance patient care across reimbursement models, leveraging technology and population health expertise. NGBC’s partnership with Privia wil...
05-27 13:00
Privia Health files Form 3 for director Francis S. Soistman Jr
Privia Health files Form 3 for director Francis S. Soistman Jr Privia Health filed an initial beneficial ownership statement naming Francis S. Soistman Jr as a director, dated May 20. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. Whil
05-22 20:24
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.469B Est
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2.350 billion-$2.450 billion vs $2.469 billion estimate.
05-07 18:01
BRIEF-Privia Health Group Q1 EPS USD 0.02
BRIEF-Privia Health Group Q1 EPS USD 0.02 May 07 (Reuters) - Privia Health Group Q1 operating income USD 7.4 million. Q1 adjusted EBITDA USD 36.7 million vs. IBES estimate USD 34.1 million Q1 net income USD 3.1 million Q1 revenue USD 603.8 million vs. IBES estimate USD 580.7 million
05-07 18:00
Privia Health CFO David Mountcastle disposes 8,385 shares worth $209,918.70
Privia Health CFO David Mountcastle disposes 8,385 shares worth $209,918.70 Privia Health CFO David Mountcastle sold 8,385 common shares in transactions dated May 1 and May 4. Sales were executed at USD 25.03 and USD 25 per share, following option exercises at USD 2 per share. Direct holdings ended
05-06 08:08
美股大行评级 | 瑞银上调美光科技目标价从510升至535美元；巴克莱下调Robinhood 目标价从124降至89美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5美元升至5.25美元；Benchmark：维持Direct Digital Holdings"投机性买入"评级，目标价从2美元升至8美元
04-09 10:15
Privia Health Group announces annual shareholder meeting via webcast
Privia Health Group announces annual shareholder meeting via webcast Privia Health schedules virtual annual stockholder meeting for May 20, 2026. Shareholders will vote on election of three Class I director nominees to serve until 2029. Ballot also includes an advisory vote on named executive office
04-02 19:56
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $23 to $25.
03-25 21:26
